200 related articles for article (PubMed ID: 24397126)
21. Cyclophilin A (CypA) is associated with the inflammatory infiltration and alveolar bone destruction in an experimental periodontitis.
Liu L; Li C; Cai C; Xiang J; Cao Z
Biochem Biophys Res Commun; 2010 Jan; 391(1):1000-6. PubMed ID: 19968957
[TBL] [Abstract][Full Text] [Related]
22. Revision Total Hip Arthroplasty with Retained Acetabular Component.
Adelani MA; Mall NA; Nyazee H; Clohisy JC; Barrack RL; Nunley RM
J Bone Joint Surg Am; 2014 Jun; 96(12):1015-1020. PubMed ID: 24951737
[TBL] [Abstract][Full Text] [Related]
23. [New metod for quantification of UHMWPE wear particles around joint replacements].
Pokorný D; Slouf M; Dybal J; Zolotarevová E; Veselý F; Jahoda D; Vavrík P; Landor I; Entlicher G; Sosna A
Acta Chir Orthop Traumatol Cech; 2009 Oct; 76(5):374-81. PubMed ID: 19912700
[TBL] [Abstract][Full Text] [Related]
24. EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
Schmidt R; Redecke V; Breitfeld Y; Wantia N; Miethke T; Massberg S; Fischel S; Neumann FJ; Schömig A; May AE
Thromb Haemost; 2006 Jan; 95(1):151-8. PubMed ID: 16543974
[TBL] [Abstract][Full Text] [Related]
25. [Neutrophil enhanced matrix metalloproteinase production and invasion of synoviocytes of RA via CD147].
Liang XH; Zhu P; Yang Y; Wang L; Zheng ZH; Ding J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Sep; 23(9):827-30. PubMed ID: 17825230
[TBL] [Abstract][Full Text] [Related]
26. [Distribution of UHMWPE wear particles in periprosthetic tissues of total hip replacements].
Pokorný D; Slouf M; Veselý F; Fulín P; Jahoda D; Sosna A
Acta Chir Orthop Traumatol Cech; 2010 Apr; 77(2):87-92. PubMed ID: 20447349
[TBL] [Abstract][Full Text] [Related]
27. Receptor activator of NF-kappaB ligand enhances breast cancer-induced osteolytic lesions through upregulation of extracellular matrix metalloproteinase inducer/CD147.
Rucci N; Millimaggi D; Mari M; Del Fattore A; Bologna M; Teti A; Angelucci A; Dolo V
Cancer Res; 2010 Aug; 70(15):6150-60. PubMed ID: 20631064
[TBL] [Abstract][Full Text] [Related]
28. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque.
Yoon YW; Kwon HM; Hwang KC; Choi EY; Hong BK; Kim D; Kim HS; Cho SH; Song KS; Sangiorgi G
Atherosclerosis; 2005 May; 180(1):37-44. PubMed ID: 15823273
[TBL] [Abstract][Full Text] [Related]
29. MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model.
Chen D; Zhang X; Guo Y; Shi S; Mao X; Pan X; Cheng T
Int J Mol Med; 2012 Dec; 30(6):1417-23. PubMed ID: 23027468
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis.
Dong W; Xiang J; Li C; Cao Z; Huang Z
J Periodontal Res; 2009 Feb; 44(1):125-32. PubMed ID: 19515022
[TBL] [Abstract][Full Text] [Related]
31. Extracellular matrix metalloproteinase inducer regulates metalloproteinases in human uterine endometrium.
Braundmeier AG; Fazleabas AT; Lessey BA; Guo H; Toole BP; Nowak RA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2358-65. PubMed ID: 16522689
[TBL] [Abstract][Full Text] [Related]
32. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
[TBL] [Abstract][Full Text] [Related]
33. [High glucose and tea polyphenols on expression of matrix metalloproteinase-2 and extracellular matrix metalloproteinase inducer in human umbilical vein endothelial cells].
Chen LL; Deng H; Li Q; Chen PS
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):532-6. PubMed ID: 20021964
[TBL] [Abstract][Full Text] [Related]
34. The membrane-type-matrix metalloproteinase/matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodeling in loose total-hip prostheses.
Takagi M; Santavirta S; Ida H; Ishii M; Akimoto K; Saotome K; Konttinen YT
Lab Invest; 1998 Jun; 78(6):735-42. PubMed ID: 9645764
[TBL] [Abstract][Full Text] [Related]
35. Increasing expression of extracellular matrix metalloprotease inducer in renal cell carcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Jin JS; Hsieh DS; Lin YF; Wang JY; Sheu LF; Lee WH
Int J Urol; 2006 May; 13(5):573-80. PubMed ID: 16771728
[TBL] [Abstract][Full Text] [Related]
36. The role of extracellular matrix metalloproteinase inducer (EMMPRIN) in the regulation of bovine endometrial cell functions.
Mishra B; Kizaki K; Sato T; Ito A; Hashizume K
Biol Reprod; 2012 Jun; 87(6):149. PubMed ID: 23115270
[TBL] [Abstract][Full Text] [Related]
37. MRI with state-of-the-art metal artifact reduction after total hip arthroplasty: periprosthetic findings in asymptomatic and symptomatic patients.
Filli L; Jungmann PM; Zingg PO; Rüdiger HA; Galley J; Sutter R; Pfirrmann CWA
Eur Radiol; 2020 Apr; 30(4):2241-2252. PubMed ID: 31863147
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium.
Konttinen YT; Li TF; Mandelin J; Liljeström M; Sorsa T; Santavirta S; Virtanen I
Arthritis Rheum; 2000 Feb; 43(2):275-80. PubMed ID: 10693866
[TBL] [Abstract][Full Text] [Related]
39. The bone-vacuum cementing technique for the fixation of the stem in total hip arthroplasty.
Pitto RP; Kessler M; Schikora N; di Muria GV
Chir Organi Mov; 2001; 86(2):99-110. PubMed ID: 12025052
[TBL] [Abstract][Full Text] [Related]
40. Messenger ribonucleic acid expression of 16 matrix metalloproteinases in bone-implant interface tissues of loose artificial hip joints.
Takei I; Takagi M; Santavirta S; Ida H; Ishii M; Ogino T; Ainola M; Konttinen YT
J Biomed Mater Res; 2000 Dec; 52(4):613-20. PubMed ID: 11033543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
